Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients
JAMA Network Open · 2023
DOI: 10.1001/jamanetworkopen.2023.37602 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, 2023. Verfasst von Amy G Feldman und 58 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Health Institute, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado and Children's Hospital Colorado,…. Hauptthemen laut MEDLINE: Viral Vaccines, Chickenpox, Mumps, Rubella. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Importance Live vaccines (measles-mumps-rubella [MMR] and varicella-zoster virus [VZV]) have not been recommended after solid organ transplant due to concern for inciting vaccine strain infection in an immunocompromised host. However, the rates of measles, mumps, and varicella are rising nationally and internationally, leaving susceptible immunocompromised children at risk for life-threating conditions.
Objective
To determine the safety and immunogenicity of live vaccines in pediatric liver and kidney transplant recipients. Design, Setting, and Participants This cohort study included select pediatric liver and kidney transplant recipients who had not completed their primary MMR and VZV vaccine series and/or who displayed nonprotective serum antibody levels at enrollment between January 1, 2002, and February 28, 2023. Eligibility for live vaccine was determined by individual US pediatric solid organ transplant center protocols. Exposures Exposure was defined as receipt of a posttransplant live vaccine. Transplant recipients received 1 to 3 doses of MMR vaccine and/or 1 to 3 doses of VZV vaccine. Main Outcome and Measure Safety data were collected following each vaccination, and antibody levels were obtained at 0 to 3 months and 1 year following vaccination. Comparisons were performed using Mann-Whitney U test, and factors associated with development of postvaccination protective antibodies were explored using univariate analysis.
Results
The cohort included 281 children (270 [96%] liver, 9 [3%] kidney, 2 [1%] liver-kidney recipients) from 18 centers. The median time from transplant to enrollment was 6.3 years (IQR, 3.4-11.1 years). The median age at first posttransplant vaccine was 8.9 years (IQR, 4.7-13.8 years). A total of 202 of 275 (73%) children were receiving low-level monotherapy immunosuppression at the time of vaccination. The majority of children developed protective antibodies following vaccination (107 of 149 [72%] varicella, 130 of 152 [86%] measles, 100 of 120 [83%] mumps, and 124 of 125 [99%] rubella). One year post vaccination, the majority of children who initially mounted protective antibodies maintained this protection (34 of 44 [77%] varicella, 45 of 49 [92%] measles, 35 of 42 [83%] mumps, 51 of 54 [94%] rubella). Five children developed clinical varicella, all of which resolved within 1 week. There were no cases of measles or rubella and no episodes of graft rejection within 1 month of vaccination. There was no association between antibody response and immunosuppression level at the time of vaccination. Conclusions and Relevance The findings suggest that live vaccinations may be safe and immunogenic after solid organ transplant in select pediatric recipients and can offer protection against circulating measles, mumps, and varicella.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Digestive Health Institute, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado and Children's Hospital Colorado, Aurora.
- Adult & Child Center for Outcomes Research & Delivery Science (ACCORDS), University of Colorado and Children's Hospital Colorado, Aurora.
- Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.
- Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio.
- Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia.
- Intermountain Primary Children's Hospital, Salt Lake City, Utah.
Förderung
- NCATS NIH HHS
Zitieren
APA
Feldman, A. G., Beaty, B. L., Ferrolino, J. A., Maron, G., Weidner, H. K., Ali, S. A., Bitterfeld, L., Boulware, M. A., Campbell, K. M., Carr, E., Chapman, S., Chang, Y. C., Cunningham, R., Dallas, R. H., Dantuluri, K. L., Domenick, B. N., Ebel, N. H., Elisofon, S., Fawaz, R., …, & Danziger-Isakov, L. A. (2023). Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.37602
Vancouver
Feldman AG, Beaty BL, Ferrolino JA, Maron G, Weidner HK, Ali SA, et al. Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.37602
BibTeX
@article{Feldman2023,
author = {Feldman, Amy G and Beaty, Brenda L and Ferrolino, Jose A and Maron, Gabriela and Weidner, Hillary K and Ali, Saira A and Bitterfeld, Leandra and Boulware, Mary Alice and Campbell, Kathleen M and Carr, Emily and Chapman, Shelley and Chang, Yeh-Chung and Cunningham, Ryan and Dallas, Ronald H and Dantuluri, Keerti L and Domenick, Bryanna N and Ebel, Noelle H and Elisofon, Scott and Fawaz, Rima and Foca, Marc and Gans, Hayley A and Gopalareddy, Vani V and Gu, Cindy and Gupta, Nitika A and Harmann, Katherine and Hollenbeck, Jessica and Huppler, Anna R and Jaramillo, Catalina and Kasi, Nagraj and Kerkar, Nanda and Lerret, Stacee and Lobritto, Steven J and Lopez, Maclovio J and Marini, Elizabeth and Mavis, Alisha and Mehra, Sonia and Moats, Lynnette and Mohandas, Sindhu and Munoz, Flor M and Mysore, Krupa R and Onsan, Ceren and Ovchinsky, Nadia and Perkins, Kerrigan and Postma, Stacy and Pratscher, Lauren and Rand, Elizabeth B and Rowe, Regina K and Schultz, Danielle and Sear, Katherine and Sell, Megan L and Sharma, Tanvi and Stoll, Janis and Vang, Mychoua and Villarin, Dominique and Weaver, Carly and Wood, Phoebe and Woodford-Berry, Olivia and Yanni, George and Danziger-Isakov, Lara A},
title = {Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients},
journal = {JAMA Network Open},
year = {2023},
doi = {10.1001/jamanetworkopen.2023.37602}
}
EUVIMED